HuGE Literature Finder
Records
1
-
9
| The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma. Experimental hematology 2020 Aug . Ishibashi Mariko, Sunakawa-Kii Mika, Kaito Yuta, Kinoshita Ryosuke, Asayama Toshio, Kuribayashi Yasuko, Inokuchi Koiti, Morita Rimpei, Tamura Hide |
| [Expression Analysis and Epigenetics of MicroRNA-28-5p in Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi 2019 10 27 (5): 1540-1547. Gao Yi-Nan, Ma Yan-Pi |
| Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood 2018 6 132 (6): 587-597. Walker Brian A, Mavrommatis Konstantinos, Wardell Christopher P, Ashby T Cody, Bauer Michael, Davies Faith E, Rosenthal Adam, Wang Hongwei, Qu Pingping, Hoering Antje, Samur Mehmet, Towfic Fadi, Ortiz Maria, Flynt Erin, Yu Zhinuan, Yang Zhihong, Rozelle Dan, Obenauer John, Trotter Matthew, Auclair Daniel, Keats Jonathan, Bolli Niccolo, Fulciniti Mariateresa, Szalat Raphael, Moreau Philippe, Durie Brian, Stewart A Keith, Goldschmidt Hartmut, Raab Marc S, Einsele Hermann, Sonneveld Pieter, San Miguel Jesus, Lonial Sagar, Jackson Graham H, Anderson Kenneth C, Avet-Loiseau Herve, Munshi Nikhil, Thakurta Anjan, Morgan Gareth |
| Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia 2018 01 32 (1): 102-110. Shah V, Sherborne A L, Walker B A, Johnson D C, Boyle E M, Ellis S, Begum D B, Proszek P Z, Jones J R, Pawlyn C, Savola S, Jenner M W, Drayson M T, Owen R G, Houlston R S, Cairns D A, Gregory W M, Cook G, Davies F E, Jackson G H, Morgan G J, Kaiser M |
| Mutational landscape reflects the biological continuum of plasma cell dyscrasias. Blood cancer journal 2017 Feb 7 (2): e537. Rossi A, Voigtlaender M, Janjetovic S, Thiele B, Alawi M, März M, Brandt A, Hansen T, Radloff J, Schön G, Hegenbart U, Schönland S, Langer C, Bokemeyer C, Binder |
| Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma. Genetics and molecular research : GMR 2015 14 (2): 5856-61. Wang S, Huang Y, Su R, Fang Z, Han |
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
Nature genetics 2013 Mar . Weinhold N, Johnson DC, Chubb D, Chen B, Försti A, Hosking FJ, Broderick P, Ma YP, Dobbins SE, Hose D, Walker BA, Davies FE, Kaiser MF, Li NL, Gregory WA, Jackson GH, Witzens-Harig M, Neben K, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Ross FM, Jauch A, Goldschmidt H, Houlston RS, Morgan GJ, Hemminki K |
| Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer research 2008 1 68 (1): 44-54. Heller Gerwin, Schmidt Wolfgang M, Ziegler Barbara, Holzer Sonja, Müllauer Leonhard, Bilban Martin, Zielinski Christoph C, Drach Johannes, Zöchbauer-Müller Sabi |
| Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma. The Journal of experimental medicine 2008 7 205 (8): 1843-58. Liu Hui, Huang Jing, Wang Jin, Jiang Shuguang, Bailey Alexis S, Goldman Devorah C, Welcker Markus, Bedell Victoria, Slovak Marilyn L, Clurman Bruce, Thayer Mathew, Fleming William H, Epner Elli |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: